Protagenic Therapeutics, Inc.\new (PTIX) Cash from Financing Activities (2014 - 2026)
Protagenic Therapeutics, Inc.\new (PTIX) reported Cash from Financing Activities of -$533,898 for fiscal Q4 2026 (quarter ended Mar 31, 2026), compared with $102,519 a year earlier.
Powered by 
Analysis
Protagenic Therapeutics, Inc.\new (PTIX) Cash from Financing Activities (2014 - 2026) Analysis & Trends
For FY2026 (ended Mar 31, 2026), Protagenic Therapeutics, Inc.\new posted Cash from Financing Activities of $3.87 million, up 114.1% from FY2025.
- Cash from Financing Activities has a five-year compound annual growth rate of -21.0% (FY2021 to FY2026).
- By fiscal year, Cash from Financing Activities came in at $1.81 million in FY2025 and $1.96 million in FY2024.
- Five-year quarterly Cash from Financing Activities spans a low of -$599,285 in fiscal Q2 2026 and a high of $5.01 million in fiscal Q1 2026.
- Per Business Quant data, the three fiscal quarters before Q4 2026 came in at -$2.00 (Q3 2026), -$599,285 (Q2 2026) and $5.01 million (Q1 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 8.43 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | -8.78 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | -5.05 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 1.76 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | -2.02 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | -3.89 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | -1.48 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 2.34 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | -3.66 Bn |
| 10 | Protagenic Therapeutics, Inc.\new | 1.38 Mn | 1.38 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | -533,898.00 |
| Dec 31, 2025 | -2.00 |
| Sep 30, 2025 | -599,285.00 |
| Jun 30, 2025 | 5.01 Mn |
| Mar 31, 2025 | 102,519.00 |
| Dec 31, 2024 | 1.60 Mn |
| Sep 30, 2024 | 316,959.00 |
| Jun 30, 2021 | 12.45 Mn |
| Mar 31, 2021 | 127,125.00 |
| Sep 30, 2020 | 323,410.00 |
| Jun 30, 2020 | 570,000.00 |
| Mar 31, 2020 | 330,000.00 |
| Dec 31, 2016 | -18,499.00 |
| Jun 30, 2016 | 505,187.00 |
| Mar 31, 2016 | 3.80 Mn |
| Dec 31, 2015 | 147,630.00 |
| Sep 30, 2015 | 50,000.00 |
| Dec 31, 2014 | 190,000.00 |
| Sep 30, 2014 | 90,000.00 |
| Mar 31, 2014 | 175,000.00 |
API Access
Protagenic Therapeutics, Inc.\new Cash from Financing Activities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=PTIX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-from-financing-activities", "ticker": "PTIX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=PTIX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();